• S. Korea To Adminster Novavax COVID-19 Vaccine In February
[Photo: AP-Newsis]  

South Korea will begin distributing the coronavirus vaccine developed by Novavax in February.

The drug safety ministry authorized the use of the two-dose protein-based vaccine by the U.S.-based biotechnology company earlier this month.

Jeong Eun-kyeong, commissioner of the Korea Disease Control and Prevention Agency, said in a regular press briefing Thursday that the vaccine is currently being manufactured by SK Bioscience in South Korea.

The unvaccinated will be given priority access to the shots, Jeong said.

Health experts are also discussing the possibility of using Novavax as the second dose for those who recieved other vaccines for their first shot.

Jeong added that related authorities are considering a fourth vaccine dose for immunocrompromised people.

Please send comments to tbsefmnews@gmail.com / copyright © tbs. Unauthorized redistribution prohibited.

개인정보처리방침  l  영상정보처리기기방침  l  사이버 감사실  l  저작권 정책  l  광고 • 협찬단가표  l  시청자 위원회  l  정보공개

03909 서울특별시 마포구 매봉산로 31 S-PLEX CENTER | 문의전화 : 02-311-5114(ARS)
Copyright © Since 2020 Seoul Traffic Broadcasting. All Rights Reserved.